No phaseEnrolling by invitationAge-related condition

Intra-articular Vitamin D3 Injection for Patients With Temporomandibular Joint Osteoarthritis

Efficacy of Intra-Articular Vitamin D3 Injection for Treatment of Temporomandibular Joint Osteoarthritis: A Randomized Clinical Trial

Sponsor
Cairo University (Academic or other)
Enrollment
26 planned
Conditions
Temporomandibular Joint Osteoarthritis
Interventions
Vitamin D3 (Cholecalciferol); Normal Saline
Ages
adults, older adults
Registry
NCT07929103

Full record on ClinicalTrials.gov

From the registry

The goal of this clinical trial is to evaluate the efficacy of intra-articular Vitamin D3 injection for the treatment of temporomandibular joint (TMJ) osteoarthritis. The main questions it aims to answer are: is intra-articular Vitamin D3 injection more effective than placebo in the treatment of temporomandibular joint osteoarthritis? . Does it improve secondary clinical outcomes such as pain-free mouth opening and remove TMJ sounds? Researchers will compare Vitamin D3 to a normal saline placebo group to see if intra-articular Vitamin D3 provides therapeutic benefits. Participants will:Undergo a diagnostic evaluation including a questionnaire, clinical examination, and MRI. Receive a single intra-articular injection of either 1 ml of Vitamin D3 (Cholecalciferol 200,000 IU) or 1 ml of normal saline into the superior joint compartment. Attend follow-up visits at two weeks, three months, and six months to assess pain scores, mouth opening, and presence of tmj sound.

Primary outcomes

  • Change from Baseline in Pain intensity will be assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Higher scores indicate greater pain intensity (worse outcome)

History

  1. Primary completion expected

  2. Last registry update

  3. Registered

  4. Started